Works by Okishio, Kyoichi


Results: 34
    1

    Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Masahiro Morimoto;
    • Kyoichi Okishio;
    • Masanori Akira;
    • Naoki Omachi;
    • Akihiro Tamiya;
    • Kazuhiro Asami;
    • Tomoya Kawaguchi;
    • Shinji Atagi;
    • Morimoto, Masahiro;
    • Okishio, Kyoichi;
    • Akira, Masanori;
    • Omachi, Naoki;
    • Tamiya, Akihiro;
    • Asami, Kazuhiro;
    • Kawaguchi, Tomoya;
    • Atagi, Shinji
    Publication type:
    journal article
    2
    3
    4

    NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC: translational research of phase III IMPACT study.

    Published in:
    Molecular Oncology, 2024, v. 18, n. 2, p. 305, doi. 10.1002/1878-0261.13542
    By:
    • Ikeda, Satoshi;
    • Tsuboi, Masahiro;
    • Sakai, Kazuko;
    • Misumi, Toshihiro;
    • Akamatsu, Hiroaki;
    • Shoda, Hiroyasu;
    • Sakakura, Noriaki;
    • Nakamura, Atsushi;
    • Ohde, Yasuhisa;
    • Hayashi, Hidetoshi;
    • Okishio, Kyoichi;
    • Okada, Morihito;
    • Yoshino, Ichiro;
    • Okami, Jiro;
    • Takahashi, Kazuhisa;
    • Ikeda, Norihiko;
    • Tanahashi, Masayuki;
    • Tambo, Yuichi;
    • Saito, Haruhiro;
    • Toyooka, Shinichi
    Publication type:
    Article
    5

    Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations.

    Published in:
    Medical Oncology, 2015, v. 32, n. 3, p. 1, doi. 10.1007/s12032-014-0474-x
    By:
    • Tamiya, Akihiro;
    • Tamiya, Motohiro;
    • Shiroyama, Takayuki;
    • Saijo, Nobuhiko;
    • Nakatani, Takeshi;
    • Minomo, Shojiro;
    • Tsuji, Taisuke;
    • Takeuchi, Naoko;
    • Omachi, Naoki;
    • Kurata, Kanako;
    • Suzuki, Hidekazu.;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Atagi, Shinji
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non‐small‐cell lung cancer in KEYNOTE‐407.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3330, doi. 10.1111/cas.15816
    By:
    • Sugawara, Shunichi;
    • Tanaka, Kentaro;
    • Imamura, Fumio;
    • Yamamoto, Nobuyuki;
    • Nishio, Makoto;
    • Okishio, Kyoichi;
    • Hirashima, Tomonori;
    • Tanaka, Hiroshi;
    • Fukuhara, Tatsuro;
    • Nakahara, Yasuharu;
    • Kurata, Takayasu;
    • Katakami, Nobuyuki;
    • Okada, Morihito;
    • Horinouchi, Hidehito;
    • Udagawa, Hibiki;
    • Kasahara, Kazuo;
    • Satouchi, Miyako;
    • Saka, Hideo;
    • Tokito, Takaaki;
    • Hosomi, Yukio
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25

    Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience.

    Published in:
    Clinical Medicine Insights: Oncology, 2019, v. 13, p. N.PAG, doi. 10.1177/1179554918821314
    By:
    • Takeda, Maiko;
    • Kasai, Takahiko;
    • Naito, Maiko;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Saijo, Nobuhiko;
    • Naoki, Yoko;
    • Okishio, Kyoichi;
    • Shimizu, Shigeki;
    • Kojima, Kensuke;
    • Nagoya, Akihiro;
    • Sakamoto, Tetsuki;
    • Utsumi, Tomoki;
    • Yoon, Hyung-Eun;
    • Matsumura, Akihide;
    • Atagi, Shinji
    Publication type:
    Article
    26

    Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience.

    Published in:
    Clinical Medicine Insights: Oncology, 2019, v. 13, p. N.PAG, doi. 10.1177/1179554918821314
    By:
    • Takeda, Maiko;
    • Kasai, Takahiko;
    • Naito, Maiko;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Saijo, Nobuhiko;
    • Naoki, Yoko;
    • Okishio, Kyoichi;
    • Shimizu, Shigeki;
    • Kojima, Kensuke;
    • Nagoya, Akihiro;
    • Sakamoto, Tetsuki;
    • Utsumi, Tomoki;
    • Yoon, Hyung-Eun;
    • Matsumura, Akihide;
    • Atagi, Shinji
    Publication type:
    Article
    27
    28
    29

    Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non–small cell lung cancer patients with asymptomatic brain metastases.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 6, p. 1598, doi. 10.1007/s10637-021-01147-w
    By:
    • Kaneda, Hiroyasu;
    • Sawa, Kenji;
    • Daga, Haruko;
    • Okada, Asuka;
    • Nakatani, Yuki;
    • Atagi, Shinji;
    • Okishio, Kyoichi;
    • Tani, Yoko;
    • Matsumoto, Yoshiya;
    • Ogawa, Koichi;
    • Nakahama, Kenji;
    • Izumi, Motohiro;
    • Mitsuoka, Shigeki;
    • Kawaguchi, Tomoya
    Publication type:
    Article
    30

    Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab‐paclitaxel for non‐squamous non‐small cell lung cancer with malignant pleural effusion.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 4, p. 1106, doi. 10.1007/s10637-021-01076-8
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Suzuki, Hidekazu;
    • Taniguchi, Yoshihiko;
    • Katayama, Kanako;
    • Minomo, Shojiro;
    • Nakao, Keiko;
    • Takeuchi, Naoko;
    • Matsuda, Yoshinobu;
    • Naito, Yujiro;
    • Shiroyama, Takayuki;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Kumagai, Toru;
    • Atagi, Shinji;
    • Imamura, Fumio;
    • Hirashima, Tomonori
    Publication type:
    Article
    31
    32

    Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations.

    Published in:
    Investigational New Drugs, 2018, v. 36, n. 4, p. 608, doi. 10.1007/s10637-017-0527-z
    By:
    • Tamiya, Motohiro;
    • Tamiya, Akihiro;
    • Shiroyama, Takayuki;
    • Takeoka, Sawa;
    • Naito, Yujiro;
    • Omachi, Naoki;
    • Kimura, Yohei;
    • Morishita, Naoko;
    • Suzuki, Hidekazu;
    • Okamoto, Norio;
    • Okishio, Kyoichi;
    • Kawaguchi, Tomoya;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    33

    Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.

    Published in:
    European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 503, doi. 10.1007/s00228-023-03452-0
    By:
    • Tanizaki, Satoshi;
    • Matsumoto, Kinnosuke;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Matsuda, Yoshinobu;
    • Uchida, Junji;
    • Ueno, Kiyonobu;
    • Kawachi, Hayato;
    • Tamiya, Motohiro;
    • Yanase, Takafumi;
    • Suzuki, Hidekazu;
    • Okishio, Kyoichi
    Publication type:
    Article
    34